Last Updated: June 24, 2026

Suppliers and packagers for TEPADINA AND SODIUM CHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


TEPADINA AND SODIUM CHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Adienne Sa TEPADINA AND SODIUM CHLORIDE thiotepa POWDER;INTRAVENOUS 208264 NDA Amneal Pharmaceuticals LLC 70121-1630-1 1 VIAL, GLASS in 1 BOX (70121-1630-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS 2017-08-15
Adienne Sa TEPADINA AND SODIUM CHLORIDE thiotepa POWDER;INTRAVENOUS 208264 NDA Amneal Pharmaceuticals LLC 70121-1631-1 1 VIAL, GLASS in 1 BOX (70121-1631-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS 2017-08-15
Adienne Sa TEPADINA AND SODIUM CHLORIDE thiotepa POWDER;INTRAVENOUS 208264 NDA Amneal Pharmaceuticals LLC 70121-1687-1 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (70121-1687-1) 2025-04-18
Adienne Sa TEPADINA AND SODIUM CHLORIDE thiotepa POWDER;INTRAVENOUS 208264 NDA Amneal Pharmaceuticals LLC 70121-2749-1 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (70121-2749-1) 2025-04-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Tepadina and Sodium Chloride: Who Manufactures Each API/Drug and How Supply Chains Typically Map

Last updated: June 6, 2026

Executive summary

  • “TEPADINA” is a brand name, and suppliers depend on the country, dosage form, and whether Tepadina is supplied as a finished medicinal product or as a component.
  • Sodium chloride is supplied broadly as USP/NF and Ph. Eur grades for injection, irrigation, inhalation, and lab/industrial use. Major supplier groups include Hospira/ Pfizer legacy supply chains (brands vary by market), Baxter, B. Braun, ICU Medical, and global sterile manufacturers, plus API and sterile fill-finish players.
  • To map suppliers precisely, you need the exact marketed presentation for Tepadina (strength and form) and the regulatory market (US, EU, UK, or specific country). With only the brand term “TEPADINA,” a definitive supplier roster cannot be stated.

Who supplies Tepadina (tepadine) and what do those suppliers typically include?

Short answer: Tepadina suppliers can be finished-product manufacturers or sourcing channels that include API makers, sterilization, and fill-finish sites. Without the exact Tepadina drug substance name and formulation, a complete supplier list cannot be produced.

What is “Tepadina” used for and how does that affect supplier selection?

Tepadina is commonly referenced as a brand for a medicinal product whose supply chain is driven by:

  • Dosage form (oral vs injectable vs ophthalmic/other)
  • Sterility requirements (if injection or ophthalmic)
  • Controlled labeling and traceability requirements by the importing regulator
  • Local marketing authorization holders (MAH) that contract multiple manufacturers

Which supplier types matter for Tepadina procurement?

In practice, procurement teams map Tepadina supply into:

  1. Marketing Authorization Holder (MAH) in the target jurisdiction
  2. Finished-product manufacturer (site that releases the product)
  3. API manufacturer (for outsourced API)
  4. CMO fill-finish (if sterile, or if packaging is outsourced)
  5. Distributor/wholesaler operating in-country

What patents or exclusivity determine who can supply Tepadina?

Short answer: Supplier eligibility is influenced more by regulatory authorization and patent status of the specific branded product and its formulation, not by “TEPADINA” alone. Without the exact active ingredient and product strength, exclusivity and barriers cannot be tied to named entities.

How do patent estates change supplier risk and entry?

Supplier landscape shifts when patents expire or when generics/authorized copies launch, typically affecting:

  • sourcing of API vs finished product
  • availability of therapeutic equivalents
  • pricing power of incumbent MAH
  • number of approved local manufacturers

Who supplies sodium chloride for pharmaceutical use (injection and sterile products)?

Short answer: Sodium chloride supply is concentrated among companies that provide sterile parenteral solutions and medical-grade sterile packaging, alongside broader commodity chemical and API producers.

Sodium chloride supplier map by product category

  • Injection/sterile solutions (0.9% NaCl, other strengths): supplied by sterile fill-finish and parenteral solution manufacturers, often through multiple sites per company due to container formats.
  • Irrigation solutions and IV fluids: aligned to sterile IV/irrigation supply chains.
  • Inhalation/surgical irrigation: may use specific grades and container types, with tighter handling controls.
  • Bulk/grade sodium chloride (API-like or industrial): supplied by chemical manufacturers; not always acceptable for sterile pharmaceutical injection without downstream sterile manufacturing.

What site capabilities typically distinguish qualified sodium chloride suppliers?

Procurement qualification usually checks:

  • Sterility assurance (aseptic processing vs terminal sterilization, depending on the formulation)
  • GMP release testing and sterility/bacterial endotoxin controls
  • Container closure system compatibility
  • Sodium chloride purity meeting USP/NF and Ph. Eur specifications
  • Stability and shelf-life for each presentation

How does sodium chloride sourcing differ between API-grade and finished sterile products?

Short answer: API-grade sodium chloride is a commodity-like raw material; finished sterile sodium chloride is a tightly regulated sterile product that depends on GMP sterile manufacturing capacity.

Typical procurement split

  • Finished sterile sodium chloride suppliers are selected through:
    • regulatory status in the target market
    • sterile manufacturing capacity and fill-finish constraints
    • packaging availability (glass vs plastic, bag vs vial, multiple sizes)
  • API/salt bulk sodium chloride is selected through:
    • grade and compliance documentation
    • impurity profile (bromide, calcium/magnesium, sulfate, insolubles)
    • supply continuity and contract terms

What “supplier” lists are actionable for tenders and contracts?

Short answer: For RFPs, tenders should request:

  • MAH and manufacturing sites for Tepadina in the destination jurisdiction
  • GMP certificates and lot release records
  • Specifications (USP/NF, Ph. Eur) for sodium chloride presentations
  • Sterile fill-finish details (for injections/irrigation)
  • Packaging/labeling compliance and distribution chain traceability

Key Takeaways

  • Tepadina supplier identification cannot be completed from “TEPADINA” alone because it is a brand term that varies by country and formulation.
  • Sodium chloride has a broad qualified supplier base, but the supplier universe splits sharply between:
    • commodity/bulk sodium chloride producers, and
    • sterile pharmaceutical fill-finish manufacturers for IV/injection/irrigation presentations.
  • The only actionable next step in procurement mapping is to anchor both products to their exact marketed presentations and the target jurisdiction, then map:
    • MAH
    • finished-product site
    • sterile fill-finish (if applicable)
    • API source (if outsourced)

FAQs

  1. How do I identify the actual manufacturer for a branded product like Tepadina in a specific country?
  2. Are sodium chloride injections sourced from the same plants as sodium chloride for irrigation and inhalation?
  3. What sodium chloride specifications (USP/NF vs Ph. Eur) matter most for sterile manufacturing supply qualification?
  4. When sodium chloride supply tightens, which bottlenecks typically drive shortages: bulk salt sourcing, sterile fill-finish, or packaging?
  5. Can a bulk sodium chloride supplier be qualified to supply sterile injection after contract manufacturing?

References

  1. USP-NF. General Requirements for Bulk Pharmaceutical Chemicals and for Drug Substances and Drug Products. United States Pharmacopeia.
  2. European Pharmacopoeia. Sodium Chloride monograph and related general chapters. European Directorate for the Quality of Medicines.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.